REGEN BIOPHARMA, INC.: cash and cash equivalents

What this measure means

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Exact concept: us-gaap:CashAndCashEquivalentsAtCarryingValue. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2012-09-30 to 2025-09-30. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• REGEN BIOPHARMA, INC.: total assets
• REGEN BIOPHARMA, INC.: total liabilities
• REGEN BIOPHARMA, INC.: stockholders equity
• REGEN BIOPHARMA, INC.: net income or loss
• REGEN BIOPHARMA, INC.: operating cash flow
• REGEN BIOPHARMA, INC.: revenue
• REGEN BIOPHARMA, INC.: contract revenue excluding tax
• REGEN BIOPHARMA, INC.: financing cash flow
• REGEN BIOPHARMA, INC.: investing cash flow
• REGEN BIOPHARMA, INC.: retained earnings or deficit
• REGEN BIOPHARMA, INC.: basic weighted-average shares
• REGEN BIOPHARMA, INC.: diluted weighted-average shares
• REGEN BIOPHARMA, INC.: basic earnings per share
• REGEN BIOPHARMA, INC.: diluted earnings per share
• REGEN BIOPHARMA, INC.: operating income or loss
• REGEN BIOPHARMA, INC.: current assets
• REGEN BIOPHARMA, INC.: interest expense
• REGEN BIOPHARMA, INC.: current liabilities
• REGEN BIOPHARMA, INC.: current accounts payable
• REGEN BIOPHARMA, INC.: net current accounts receivable
• REGEN BIOPHARMA, INC.: operating expenses
• REGEN BIOPHARMA, INC.: research and development expense

Inspect the source

Entity

REGEN BIOPHARMA, INC. / CIK 0001589150

Captured

2026-09-20T09:23:48.532Z

SEC response SHA-256

0bbe246b6080c7701ba978807745a4ba9de62971ab4db32e8d3e2fa2c4f26a87

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001589150.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))